SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008205
Filing Date
2024-05-15
Accepted
2024-05-15 07:00:33
Documents
54
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sgmt-20240331x10q.htm   iXBRL 10-Q 1053264
2 EX-31.1 sgmt-20240331xex31d1.htm EX-31.1 11876
3 EX-31.2 sgmt-20240331xex31d2.htm EX-31.2 12844
4 EX-32.1 sgmt-20240331xex32d1.htm EX-32.1 9486
  Complete submission text file 0001558370-24-008205.txt   4897874

Data Files

Seq Description Document Type Size
5 EX-101.SCH sgmt-20240331.xsd EX-101.SCH 24942
6 EX-101.CAL sgmt-20240331_cal.xml EX-101.CAL 31626
7 EX-101.DEF sgmt-20240331_def.xml EX-101.DEF 144276
8 EX-101.LAB sgmt-20240331_lab.xml EX-101.LAB 297726
9 EX-101.PRE sgmt-20240331_pre.xml EX-101.PRE 234163
58 EXTRACTED XBRL INSTANCE DOCUMENT sgmt-20240331x10q_htm.xml XML 865049
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

IRS No.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41742 | Film No.: 24947088
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)